World Journal of Surgery

, Volume 34, Issue 10, pp 2434–2441 | Cite as

Prognostic Factors and Outcome of 438 Chinese Patients with Hepatocellular Carcinoma Underwent Partial Hepatectomy in a Single Center

  • Jie Wang
  • Lei-bo Xu
  • Chao LiuEmail author
  • Hao-wei Pang
  • Ya-jin Chen
  • Qing-jia Ou



This study was designed to evaluate the prognostic factors and outcome of 438 Chinese patients with hepatocellular carcinoma who underwent partial hepatectomy in a single center.


Clinicopathological data of 438 patients with hepatocellular carcinoma who underwent partial hepatectomy at the author’s hospital between 1991 and 2004 were reviewed retrospectively. The Kaplan–Meier method was adopted for evaluating survival. Prognostic factors were assessed by Cox proportional hazard model and logistic regression model.


The perioperative (30 days) mortality and morbidity were 7.5% (33/438) and 21.7% (95/438), respectively. The operative mortality decreased significantly from 10.6% (23/218) in 1991–2001 to 4.5% (10/220) in 2002–2004 (P = 0.019). Postoperative overall survival rates at 1 year, 3 years, and 5 years were 72.2%, 53.5%, and 43.3%, respectively. Cox multivariate analysis indicated that Child-Pugh score, tumor size, capsular invasion, tumor stage, vascular invasion, and resection margin were independent prognostic factors for overall survival (P < 0.05). Also, 254 cases had tumor recurrence after operation and 87 cases of them were reoperated. Logistic multivariate analysis showed that tumor size, capsular invasion, vascular invasion, lymph node metastasis, extrahepatic metastasis, and resection margin were independent risk factors of tumor recurrence (P < 0.05).


Tumor size, capsular invasion, vascular invasion, and resection margin were the main factors that may impact the overall survival and tumor recurrence. Because resection margin was the only factor that relates to the surgery, enough resection margin (>2 cm) should be obtained whenever possible.


Tace Resection Margin Vascular Invasion Partial Hepatectomy Extrahepatic Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The Special Research Foundation of the National Nature Science Foundation of China (30872487).

Conflicts of interest

The authors certify that this is an original, unpublished work that is not under consideration elsewhere. We had no conflicts of interest to disclose.


  1. 1.
    Monto A, Wright TL (2001) The epidemiology and prevention of hepatocellular carcinoma. Sem Oncol 28:441–449CrossRefGoogle Scholar
  2. 2.
    El-Serag HB, Rudolph L (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576CrossRefPubMedGoogle Scholar
  3. 3.
    Davila JA, El-Serag HB (2006) Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. Clin Gastroenterol Hepatol 4:104–110CrossRefPubMedGoogle Scholar
  4. 4.
    American Joint Committee on Cancer (2002) In: AJCC cancer staging manual, 6th edn. Springer, New York, pp 145–149Google Scholar
  5. 5.
    Belghiti J, Ogata S (2005) Assessment of hepatic reserve for the indication of hepatic resection. J Hepatobil Pancreat Surg 12:1–3CrossRefGoogle Scholar
  6. 6.
    Shimada M, Takenaka K, Taguchi K et al (1998) Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 227:80–85CrossRefPubMedGoogle Scholar
  7. 7.
    Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer 94:153–156CrossRefPubMedGoogle Scholar
  8. 8.
    Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907–1917CrossRefPubMedGoogle Scholar
  9. 9.
    Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRefPubMedGoogle Scholar
  10. 10.
    McGlynn KA, London WT (2005) Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 19:3–23CrossRefPubMedGoogle Scholar
  11. 11.
    Poon D, Anderson BO, Chen LT et al (2009) Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 10:1111–1118CrossRefPubMedGoogle Scholar
  12. 12.
    Meric F, Patt YZ, Curley SA et al (2000) Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol 7:490–495CrossRefPubMedGoogle Scholar
  13. 13.
    Song TJ, Ip EWK, Fong YM (2004) Hepatocellular carcinoma: Current surgical management. Gastroenterology 127:S248–S260CrossRefPubMedGoogle Scholar
  14. 14.
    Nagasue N, Uchida M, Makino Y et al (1993) Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular-carcinoma. Gastroenterology 105:488–494PubMedGoogle Scholar
  15. 15.
    Nakashima O, Kojiro M (2001) Recurrence of hepatocellular carcinoma: multicentric occurrence or intrahepatic metastasis? A viewpoint in terms of pathology. J Hepatobil Pancreat Surg 8:404–409CrossRefGoogle Scholar
  16. 16.
    Ng IOL, Lai ECS, Fan ST, Ng MMT, So MKP (1995) Prognostic-significance of pathological features of hepatocellular carcinoma: a multivariate-analysis of 278 patients. Cancer 76:2443–2448CrossRefPubMedGoogle Scholar
  17. 17.
    Nathan H, Schulick RD, Choti MA, Pawlik TM (2009) Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg 249:799–805CrossRefPubMedGoogle Scholar
  18. 18.
    Varotti G, Ramacciato G, Ercolani G et al (2005) Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. EJSO 31:760–767CrossRefPubMedGoogle Scholar
  19. 19.
    Zhou L, Rui JA, Ye DX, Wang SB, Chen SG, Qu Q (2008) Edmondson-Steiner grading increases the predictive efficiency of TNM staging for long-term survival of patients with hepatocellular carcinoma after curative resection. World J Surg 32:1748–1756CrossRefPubMedGoogle Scholar
  20. 20.
    Machi J, Bueno RS, Wong LL (2005) Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. World J Surg 29:1364–1373CrossRefPubMedGoogle Scholar
  21. 21.
    Yeh CN, Chen MF, Lee WC, Jeng LB (2002) Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol 81:195–202CrossRefPubMedGoogle Scholar
  22. 22.
    Neeleman N, Andersson R (1996) Repeated liver resection for recurrent liver cancer. Br J Surg 83:893–901CrossRefPubMedGoogle Scholar
  23. 23.
    Poon RTP, Fan ST, Ng IOL, Wong J (2000) Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal. Ann Surg 231:544–551CrossRefPubMedGoogle Scholar
  24. 24.
    Chau GY, Lui WY, Tsay SH et al (1997) Prognostic significance of surgical margin in hepatocellular carcinoma resection: an analysis of 165 Childs’ A patients. J Surg Oncol 66:122–126CrossRefPubMedGoogle Scholar
  25. 25.
    Regimbeau JM, Abdalla EK, Vauthey JN et al (2004) Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol 85:36–41CrossRefPubMedGoogle Scholar
  26. 26.
    Regimbeau JM, Kianmanesh R, Farges O, Dondero F, Sauvanet A, Belghiti J (2002) Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery 131:311–317CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2010

Authors and Affiliations

  • Jie Wang
    • 1
  • Lei-bo Xu
    • 1
  • Chao Liu
    • 1
    Email author
  • Hao-wei Pang
    • 2
  • Ya-jin Chen
    • 1
  • Qing-jia Ou
    • 1
  1. 1.Department of Hepato-Pancreato-Biliary Surgery, Sun Yat-Sen Memorial HospitalSun Yat-Sen UniversityGuangzhouChina
  2. 2.Department of EmergencyHuangpu Branch of the First Affiliated Hospital of Sun Yat-sen UniversityGuangzhouChina

Personalised recommendations